JWA
CORT icon

JFS Wealth Advisors’s Corcept Therapeutics CORT Stock Holding History

JFS Wealth Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04K Buy
35
+14
+67% +$845 ﹤0.01% 1467
2026
Q1 		$847 Sell
21
-52
-71% -$1.94K ﹤0.01% 1693
2025
Q4 		$2.54K Hold
73
– – ﹤0.01% 1472
2025
Q3 		$6.07K Hold
73
– – ﹤0.01% 1047
2025
Q2 		$5.36K Hold
73
– – ﹤0.01% 1060
2025
Q1 		$8.34K Hold
73
– – ﹤0.01% 935
2024
Q4 		$3.68K Hold
73
– – ﹤0.01% 1239
2024
Q3 		$3.38K Buy
73
+2
+3% +$71 ﹤0.01% 1262
2024
Q2 		$2.31K Hold
71
– – ﹤0.01% 1383
2024
Q1 		$1.79K Hold
71
– – ﹤0.01% 1486
2023
Q4 		$2.31K Hold
71
– – ﹤0.01% 1365
2023
Q3 		$1.94K Buy
71
+1
+1% +$29 ﹤0.01% 1373
2023
Q2 		$1.56K Hold
70
– – ﹤0.01% 1479
2023
Q1 		$1.52K Sell
70
-1
-1% -$22 ﹤0.01% 1462
2022
Q4 		$1.44K Sell
71
-19
-21% -$476 ﹤0.01% 1495
2022
Q3 		$2K Sell
90
-7
-7% -$187 ﹤0.01% 1296
2022
Q2 		$2K Buy
97
+34
+54% +$741 ﹤0.01% 1297
2022
Q1 		$1K Buy
63
+39
+163% +$830 ﹤0.01% 1607
2021
Q4 		$0 Buy
+24
New +$487 ﹤0.01% 1740

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JFS Wealth Advisors's CORT Position: Q2 2026 in Review

JFS Wealth Advisors increased its Corcept Therapeutics (CORT) stake by 67% in Q2 2026, buying an estimated $845 and bringing the position to 35 shares worth $3.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

JFS Wealth Advisors first reported a position in CORT in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.34K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • JFS Wealth Advisors held 35 shares of Corcept Therapeutics worth $3.04K as of Q2 2026.
  • JFS Wealth Advisors bought 14 Corcept Therapeutics shares in Q2 2026, an estimated $845.
  • Corcept Therapeutics made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1467 holding.
  • JFS Wealth Advisors first reported a position in Corcept Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • JFS Wealth Advisors's Corcept Therapeutics position peaked at $8.34K in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.